1174631-13-0

Basic information

• Product Name: (6-chloro-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-(4-methanesulfonyl-phenyl)carbamic acid tert-butyl ester
• Synonyms: (6-chloro-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-(4-methanesulfonyl-phenyl)carbamic acid tert-butyl ester
• CAS NO: 1174631-13-0
• Molecular Weight: 437.907
• Mol File: 1174631-13-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (6-chloro-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-(4-methanesulfonyl-phenyl)carbamic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (6-chloro-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-(4-methanesulfonyl-phenyl)carbamic acid tert-butyl ester(1174631-13-0)
• EPA Substance Registry System: (6-chloro-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-(4-methanesulfonyl-phenyl)carbamic acid tert-butyl ester(1174631-13-0)

Safety Data

• Hazardous Substances Data: 1174631-13-0(Hazardous Substances Data)

Upstream product

• 98141-42-5 4,6-dichloro-1-methyl-1H-pyrazolo[3,4-d]pyrimidine 
• 1096711-96-4 tert-butyl N-(4-methylsulfonylphenyl)carbamate 

Relevant articles and documents

PYRAZOLOPYRIMIDINE PI3K INHIBITOR COMPOUNDS AND METHODS OF USE

Compounds of Formula I, and including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting lipid kinases including p110 alpha and other isoforms of PI3K, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed. [Fomula I]